Thus, in human hepatoma cells, it was shown that dexamethasone treatment increased HIF-1α levels in the cytosol but decreased nuclear HIF-1α levels and HIF-1 binding to DNA, which resulted in suppression of hypoxia-dependent expression of the HIF-1 target gene VEGF. The gene discussed is HIF1A; the disease is hepatocellular carcinoma.